Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 571,108 | 574,453 | 457,638 | 448,317 | 675,846 |
| Marketable Securities | 9,347 | 8,186 | 7,679 | 0 | 0 |
| Receivables | 596,541 | 636,837 | 570,502 | 580,907 | 197,999 |
| Inventories | 373,673 | 364,568 | 376,760 | 420,029 | 206,581 |
| Other current assets | 156,043 | 163,082 | 142,200 | 162,918 | 67,656 |
| TOTAL | $1,706,712 | $1,747,126 | $1,554,779 | $1,612,171 | $1,148,082 |
| Non-Current Assets | |||||
| PPE Net | 1,103,669 | 1,060,388 | 1,007,120 | 990,917 | 564,243 |
| TOTAL | $1,103,669 | $1,060,388 | $1,007,120 | $990,917 | $564,243 |
| Total Assets | $9,023,845 | $9,109,321 | $8,817,174 | $8,898,759 | $3,396,073 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $1,313,121 | $1,018,572 | $889,006 | $1,007,242 | $243,706 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,798,483 | 3,342,261 | 3,369,372 | 3,396,420 | 1,150,962 |
| TOTAL | $2,798,483 | $3,342,261 | $3,369,372 | $3,396,420 | $1,150,962 |
| Total Liabilities | $5,213,974 | $5,431,453 | $5,323,877 | $5,442,221 | $1,554,506 |
| Shareholders' Equity | |||||
| Retained earnings | 105,292 | 64,156 | 25,214 | 9,610 | 225,174 |
| Other shareholders' equity | 3,704,579 | 3,613,712 | 3,468,083 | 3,446,928 | 1,616,393 |
| TOTAL | $3,809,871 | $3,677,868 | $3,493,297 | $3,456,538 | $1,841,567 |
| Total Liabilities And Equity | $9,023,845 | $9,109,321 | $8,817,174 | $8,898,759 | $3,396,073 |